Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres
Starting from phenethanolamine aniline leads 3a and 3b, we have identified a series of functionally potent and selective beta(3) adrenergic receptor (AR) agonists containing acylsulfonamide, sulfonylsulfonamide, or sulfonylurea groups within the aniline phenethanolamine series. In beta(3), beta(2),...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 2002-01, Vol.45 (3), p.567-583 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 583 |
---|---|
container_issue | 3 |
container_start_page | 567 |
container_title | Journal of medicinal chemistry |
container_volume | 45 |
creator | Uehling, David E Donaldson, Kelly H Deaton, David N Hyman, Clifton E Sugg, Elizabeth E Barrett, David G Hughes, Robert G Reitter, Barbara Adkison, Kim K Lancaster, Mary E Lee, Frank Hart, Robert Paulik, Mark A Sherman, Bryan W True, Timothy Cowan, Conrad |
description | Starting from phenethanolamine aniline leads 3a and 3b, we have identified a series of functionally potent and selective beta(3) adrenergic receptor (AR) agonists containing acylsulfonamide, sulfonylsulfonamide, or sulfonylurea groups within the aniline phenethanolamine series. In beta(3), beta(2), and beta(1) AR cAMP functional assays, 3a and other right-hand side (RHS) carboxylate analogues were found to be full agonists that were modestly selective against beta(1) or beta(2) ARs, while analogues lacking RHS acid functionality were active at beta(3) AR but not selective. Replacement of the carboxylate with acylthiazole and acylmethylsulfone gave potent, but only modestly selective, compounds. Increasing the size of the RHS sulfonamide substituent with phenyl or p-toluene afforded compounds with good potency and functional selectivity (beta(3) AR pEC(50) greater than 8; beta(1) and beta(2) AR selectivity greater than 40- and 500-fold, respectively). Our SAR studies suggest that the potency and selectivity profile of the best analogues reported here is a result of both the steric bulk and acidity of the RHS sulfonamide NH group. Although all of the analogues had a pharmacokinetic half-life of less than 2 h, acylsulfonamides 43 and 44 did show moderately low clearance in dogs. These two compounds were further evaluated by thermographic imaging in mice and were found to produce a robust thermogenic response via oral administration. |
doi_str_mv | 10.1021/jm0101500 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71416665</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71416665</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-efe22b35cb4ca9ba075abfb1fb36bb7f0c7e6118e9fa160defd8a1dd4f0d0f3e3</originalsourceid><addsrcrecordid>eNpdUMtKAzEUzUKxtbrwByQrUbB6M2ln7FKKLyi4UNflJrmpKTPJmGSK_Sz_0NLWjavDeXAOHMbOBNwIKMTtsgEBYgxwwPoARTEsykL22HFKSwCQopBHrCfEHZQVTPrs523t8ycllzh6w2mFdYfZBc-D5W3I5PPWSFSTzm5FXFHGS3nF0UTyFBdO80ia2hwix0XwLuXEdfAZnXd-wVGv69TVNnhsnKFrviP_xO3G3ugiIdcYVfhe15t61M5wl0LKFCmdsEOLdaLTPQ7Yx-PD-_R5OHt9epnez4atkJM8JEtFoeRYq5HGiUKoxqisElbJUqnKgq6o3PxAE4uiBEPW3KEwZmTBgJUkB-xi19vG8NVRyvPGJU11jZ5Cl-aVGImyLMeb4Pk-2KmGzLyNrsG4nv-dLH8BSpGDOw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71416665</pqid></control><display><type>article</type><title>Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres</title><source>MEDLINE</source><source>ACS Publications</source><creator>Uehling, David E ; Donaldson, Kelly H ; Deaton, David N ; Hyman, Clifton E ; Sugg, Elizabeth E ; Barrett, David G ; Hughes, Robert G ; Reitter, Barbara ; Adkison, Kim K ; Lancaster, Mary E ; Lee, Frank ; Hart, Robert ; Paulik, Mark A ; Sherman, Bryan W ; True, Timothy ; Cowan, Conrad</creator><creatorcontrib>Uehling, David E ; Donaldson, Kelly H ; Deaton, David N ; Hyman, Clifton E ; Sugg, Elizabeth E ; Barrett, David G ; Hughes, Robert G ; Reitter, Barbara ; Adkison, Kim K ; Lancaster, Mary E ; Lee, Frank ; Hart, Robert ; Paulik, Mark A ; Sherman, Bryan W ; True, Timothy ; Cowan, Conrad</creatorcontrib><description>Starting from phenethanolamine aniline leads 3a and 3b, we have identified a series of functionally potent and selective beta(3) adrenergic receptor (AR) agonists containing acylsulfonamide, sulfonylsulfonamide, or sulfonylurea groups within the aniline phenethanolamine series. In beta(3), beta(2), and beta(1) AR cAMP functional assays, 3a and other right-hand side (RHS) carboxylate analogues were found to be full agonists that were modestly selective against beta(1) or beta(2) ARs, while analogues lacking RHS acid functionality were active at beta(3) AR but not selective. Replacement of the carboxylate with acylthiazole and acylmethylsulfone gave potent, but only modestly selective, compounds. Increasing the size of the RHS sulfonamide substituent with phenyl or p-toluene afforded compounds with good potency and functional selectivity (beta(3) AR pEC(50) greater than 8; beta(1) and beta(2) AR selectivity greater than 40- and 500-fold, respectively). Our SAR studies suggest that the potency and selectivity profile of the best analogues reported here is a result of both the steric bulk and acidity of the RHS sulfonamide NH group. Although all of the analogues had a pharmacokinetic half-life of less than 2 h, acylsulfonamides 43 and 44 did show moderately low clearance in dogs. These two compounds were further evaluated by thermographic imaging in mice and were found to produce a robust thermogenic response via oral administration.</description><identifier>ISSN: 0022-2623</identifier><identifier>DOI: 10.1021/jm0101500</identifier><identifier>PMID: 11806709</identifier><language>eng</language><publisher>United States</publisher><subject>Adrenergic beta-Agonists - chemical synthesis ; Adrenergic beta-Agonists - chemistry ; Adrenergic beta-Agonists - pharmacology ; Aniline Compounds - chemical synthesis ; Aniline Compounds - chemistry ; Aniline Compounds - pharmacology ; Animals ; Biological Availability ; Body Temperature - drug effects ; CHO Cells ; Chromatography, High Pressure Liquid ; Cricetinae ; Cyclic AMP - biosynthesis ; Dogs ; Humans ; Magnetic Resonance Spectroscopy ; Male ; Mass Spectrometry ; Mice ; Radioligand Assay ; Receptors, Adrenergic, beta-3 - drug effects ; Stereoisomerism ; Structure-Activity Relationship ; Sulfonamides - chemical synthesis ; Sulfonamides - chemistry ; Sulfonamides - pharmacology ; Sulfonylurea Compounds - chemical synthesis ; Sulfonylurea Compounds - chemistry ; Sulfonylurea Compounds - pharmacology ; Thermography</subject><ispartof>Journal of medicinal chemistry, 2002-01, Vol.45 (3), p.567-583</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11806709$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uehling, David E</creatorcontrib><creatorcontrib>Donaldson, Kelly H</creatorcontrib><creatorcontrib>Deaton, David N</creatorcontrib><creatorcontrib>Hyman, Clifton E</creatorcontrib><creatorcontrib>Sugg, Elizabeth E</creatorcontrib><creatorcontrib>Barrett, David G</creatorcontrib><creatorcontrib>Hughes, Robert G</creatorcontrib><creatorcontrib>Reitter, Barbara</creatorcontrib><creatorcontrib>Adkison, Kim K</creatorcontrib><creatorcontrib>Lancaster, Mary E</creatorcontrib><creatorcontrib>Lee, Frank</creatorcontrib><creatorcontrib>Hart, Robert</creatorcontrib><creatorcontrib>Paulik, Mark A</creatorcontrib><creatorcontrib>Sherman, Bryan W</creatorcontrib><creatorcontrib>True, Timothy</creatorcontrib><creatorcontrib>Cowan, Conrad</creatorcontrib><title>Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres</title><title>Journal of medicinal chemistry</title><addtitle>J Med Chem</addtitle><description>Starting from phenethanolamine aniline leads 3a and 3b, we have identified a series of functionally potent and selective beta(3) adrenergic receptor (AR) agonists containing acylsulfonamide, sulfonylsulfonamide, or sulfonylurea groups within the aniline phenethanolamine series. In beta(3), beta(2), and beta(1) AR cAMP functional assays, 3a and other right-hand side (RHS) carboxylate analogues were found to be full agonists that were modestly selective against beta(1) or beta(2) ARs, while analogues lacking RHS acid functionality were active at beta(3) AR but not selective. Replacement of the carboxylate with acylthiazole and acylmethylsulfone gave potent, but only modestly selective, compounds. Increasing the size of the RHS sulfonamide substituent with phenyl or p-toluene afforded compounds with good potency and functional selectivity (beta(3) AR pEC(50) greater than 8; beta(1) and beta(2) AR selectivity greater than 40- and 500-fold, respectively). Our SAR studies suggest that the potency and selectivity profile of the best analogues reported here is a result of both the steric bulk and acidity of the RHS sulfonamide NH group. Although all of the analogues had a pharmacokinetic half-life of less than 2 h, acylsulfonamides 43 and 44 did show moderately low clearance in dogs. These two compounds were further evaluated by thermographic imaging in mice and were found to produce a robust thermogenic response via oral administration.</description><subject>Adrenergic beta-Agonists - chemical synthesis</subject><subject>Adrenergic beta-Agonists - chemistry</subject><subject>Adrenergic beta-Agonists - pharmacology</subject><subject>Aniline Compounds - chemical synthesis</subject><subject>Aniline Compounds - chemistry</subject><subject>Aniline Compounds - pharmacology</subject><subject>Animals</subject><subject>Biological Availability</subject><subject>Body Temperature - drug effects</subject><subject>CHO Cells</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Cricetinae</subject><subject>Cyclic AMP - biosynthesis</subject><subject>Dogs</subject><subject>Humans</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Male</subject><subject>Mass Spectrometry</subject><subject>Mice</subject><subject>Radioligand Assay</subject><subject>Receptors, Adrenergic, beta-3 - drug effects</subject><subject>Stereoisomerism</subject><subject>Structure-Activity Relationship</subject><subject>Sulfonamides - chemical synthesis</subject><subject>Sulfonamides - chemistry</subject><subject>Sulfonamides - pharmacology</subject><subject>Sulfonylurea Compounds - chemical synthesis</subject><subject>Sulfonylurea Compounds - chemistry</subject><subject>Sulfonylurea Compounds - pharmacology</subject><subject>Thermography</subject><issn>0022-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUMtKAzEUzUKxtbrwByQrUbB6M2ln7FKKLyi4UNflJrmpKTPJmGSK_Sz_0NLWjavDeXAOHMbOBNwIKMTtsgEBYgxwwPoARTEsykL22HFKSwCQopBHrCfEHZQVTPrs523t8ycllzh6w2mFdYfZBc-D5W3I5PPWSFSTzm5FXFHGS3nF0UTyFBdO80ia2hwix0XwLuXEdfAZnXd-wVGv69TVNnhsnKFrviP_xO3G3ugiIdcYVfhe15t61M5wl0LKFCmdsEOLdaLTPQ7Yx-PD-_R5OHt9epnez4atkJM8JEtFoeRYq5HGiUKoxqisElbJUqnKgq6o3PxAE4uiBEPW3KEwZmTBgJUkB-xi19vG8NVRyvPGJU11jZ5Cl-aVGImyLMeb4Pk-2KmGzLyNrsG4nv-dLH8BSpGDOw</recordid><startdate>20020131</startdate><enddate>20020131</enddate><creator>Uehling, David E</creator><creator>Donaldson, Kelly H</creator><creator>Deaton, David N</creator><creator>Hyman, Clifton E</creator><creator>Sugg, Elizabeth E</creator><creator>Barrett, David G</creator><creator>Hughes, Robert G</creator><creator>Reitter, Barbara</creator><creator>Adkison, Kim K</creator><creator>Lancaster, Mary E</creator><creator>Lee, Frank</creator><creator>Hart, Robert</creator><creator>Paulik, Mark A</creator><creator>Sherman, Bryan W</creator><creator>True, Timothy</creator><creator>Cowan, Conrad</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20020131</creationdate><title>Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres</title><author>Uehling, David E ; Donaldson, Kelly H ; Deaton, David N ; Hyman, Clifton E ; Sugg, Elizabeth E ; Barrett, David G ; Hughes, Robert G ; Reitter, Barbara ; Adkison, Kim K ; Lancaster, Mary E ; Lee, Frank ; Hart, Robert ; Paulik, Mark A ; Sherman, Bryan W ; True, Timothy ; Cowan, Conrad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-efe22b35cb4ca9ba075abfb1fb36bb7f0c7e6118e9fa160defd8a1dd4f0d0f3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adrenergic beta-Agonists - chemical synthesis</topic><topic>Adrenergic beta-Agonists - chemistry</topic><topic>Adrenergic beta-Agonists - pharmacology</topic><topic>Aniline Compounds - chemical synthesis</topic><topic>Aniline Compounds - chemistry</topic><topic>Aniline Compounds - pharmacology</topic><topic>Animals</topic><topic>Biological Availability</topic><topic>Body Temperature - drug effects</topic><topic>CHO Cells</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Cricetinae</topic><topic>Cyclic AMP - biosynthesis</topic><topic>Dogs</topic><topic>Humans</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Male</topic><topic>Mass Spectrometry</topic><topic>Mice</topic><topic>Radioligand Assay</topic><topic>Receptors, Adrenergic, beta-3 - drug effects</topic><topic>Stereoisomerism</topic><topic>Structure-Activity Relationship</topic><topic>Sulfonamides - chemical synthesis</topic><topic>Sulfonamides - chemistry</topic><topic>Sulfonamides - pharmacology</topic><topic>Sulfonylurea Compounds - chemical synthesis</topic><topic>Sulfonylurea Compounds - chemistry</topic><topic>Sulfonylurea Compounds - pharmacology</topic><topic>Thermography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uehling, David E</creatorcontrib><creatorcontrib>Donaldson, Kelly H</creatorcontrib><creatorcontrib>Deaton, David N</creatorcontrib><creatorcontrib>Hyman, Clifton E</creatorcontrib><creatorcontrib>Sugg, Elizabeth E</creatorcontrib><creatorcontrib>Barrett, David G</creatorcontrib><creatorcontrib>Hughes, Robert G</creatorcontrib><creatorcontrib>Reitter, Barbara</creatorcontrib><creatorcontrib>Adkison, Kim K</creatorcontrib><creatorcontrib>Lancaster, Mary E</creatorcontrib><creatorcontrib>Lee, Frank</creatorcontrib><creatorcontrib>Hart, Robert</creatorcontrib><creatorcontrib>Paulik, Mark A</creatorcontrib><creatorcontrib>Sherman, Bryan W</creatorcontrib><creatorcontrib>True, Timothy</creatorcontrib><creatorcontrib>Cowan, Conrad</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uehling, David E</au><au>Donaldson, Kelly H</au><au>Deaton, David N</au><au>Hyman, Clifton E</au><au>Sugg, Elizabeth E</au><au>Barrett, David G</au><au>Hughes, Robert G</au><au>Reitter, Barbara</au><au>Adkison, Kim K</au><au>Lancaster, Mary E</au><au>Lee, Frank</au><au>Hart, Robert</au><au>Paulik, Mark A</au><au>Sherman, Bryan W</au><au>True, Timothy</au><au>Cowan, Conrad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J Med Chem</addtitle><date>2002-01-31</date><risdate>2002</risdate><volume>45</volume><issue>3</issue><spage>567</spage><epage>583</epage><pages>567-583</pages><issn>0022-2623</issn><abstract>Starting from phenethanolamine aniline leads 3a and 3b, we have identified a series of functionally potent and selective beta(3) adrenergic receptor (AR) agonists containing acylsulfonamide, sulfonylsulfonamide, or sulfonylurea groups within the aniline phenethanolamine series. In beta(3), beta(2), and beta(1) AR cAMP functional assays, 3a and other right-hand side (RHS) carboxylate analogues were found to be full agonists that were modestly selective against beta(1) or beta(2) ARs, while analogues lacking RHS acid functionality were active at beta(3) AR but not selective. Replacement of the carboxylate with acylthiazole and acylmethylsulfone gave potent, but only modestly selective, compounds. Increasing the size of the RHS sulfonamide substituent with phenyl or p-toluene afforded compounds with good potency and functional selectivity (beta(3) AR pEC(50) greater than 8; beta(1) and beta(2) AR selectivity greater than 40- and 500-fold, respectively). Our SAR studies suggest that the potency and selectivity profile of the best analogues reported here is a result of both the steric bulk and acidity of the RHS sulfonamide NH group. Although all of the analogues had a pharmacokinetic half-life of less than 2 h, acylsulfonamides 43 and 44 did show moderately low clearance in dogs. These two compounds were further evaluated by thermographic imaging in mice and were found to produce a robust thermogenic response via oral administration.</abstract><cop>United States</cop><pmid>11806709</pmid><doi>10.1021/jm0101500</doi><tpages>17</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 2002-01, Vol.45 (3), p.567-583 |
issn | 0022-2623 |
language | eng |
recordid | cdi_proquest_miscellaneous_71416665 |
source | MEDLINE; ACS Publications |
subjects | Adrenergic beta-Agonists - chemical synthesis Adrenergic beta-Agonists - chemistry Adrenergic beta-Agonists - pharmacology Aniline Compounds - chemical synthesis Aniline Compounds - chemistry Aniline Compounds - pharmacology Animals Biological Availability Body Temperature - drug effects CHO Cells Chromatography, High Pressure Liquid Cricetinae Cyclic AMP - biosynthesis Dogs Humans Magnetic Resonance Spectroscopy Male Mass Spectrometry Mice Radioligand Assay Receptors, Adrenergic, beta-3 - drug effects Stereoisomerism Structure-Activity Relationship Sulfonamides - chemical synthesis Sulfonamides - chemistry Sulfonamides - pharmacology Sulfonylurea Compounds - chemical synthesis Sulfonylurea Compounds - chemistry Sulfonylurea Compounds - pharmacology Thermography |
title | Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A19%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20evaluation%20of%20potent%20and%20selective%20beta(3)%20adrenergic%20receptor%20agonists%20containing%20acylsulfonamide,%20sulfonylsulfonamide,%20and%20sulfonylurea%20carboxylic%20acid%20isosteres&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Uehling,%20David%20E&rft.date=2002-01-31&rft.volume=45&rft.issue=3&rft.spage=567&rft.epage=583&rft.pages=567-583&rft.issn=0022-2623&rft_id=info:doi/10.1021/jm0101500&rft_dat=%3Cproquest_pubme%3E71416665%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71416665&rft_id=info:pmid/11806709&rfr_iscdi=true |